1991
DOI: 10.1016/0142-9612(91)90026-7
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradation and antitumour effect of adriamycin-containing poly(l-lactic acid) microspheres

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
11
0
1

Year Published

1992
1992
2022
2022

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 23 publications
(12 citation statements)
references
References 11 publications
0
11
0
1
Order By: Relevance
“…• DOX-loaded microparticles [25][26][27] • PLGA NPs [28][29][30][31] • PLGA-PEG micelles [28][29][30][31] • PLGA-vitamin E tocopheryl polyethylene glycol succinate NPs with DOX covalently conjugated to the PLGA polymer [28][29][30][31] • pH-sensitive DOX-loaded micelles of poly(Lhistidine)-PEG-folate and PLA-PEG-folate blends [32] • Self-assembled NPs of PLGA-g-pullulan loaded with DOX [33], among others • Multifunctional micelles of PLA-PEG loaded with superparamagnetic iron oxide NPs and DOX [34] Microparticle formulations have limited clinical potential since they must be locally administered or implanted. Formulations in which DOX is chemically conjugated to the drug carrier are often problematic because modification of the drug may lead to changes in its in vivo activity and creates the risk for creation of nonbiocompatible products of drug-polymer metabolism.…”
mentioning
confidence: 99%
“…• DOX-loaded microparticles [25][26][27] • PLGA NPs [28][29][30][31] • PLGA-PEG micelles [28][29][30][31] • PLGA-vitamin E tocopheryl polyethylene glycol succinate NPs with DOX covalently conjugated to the PLGA polymer [28][29][30][31] • pH-sensitive DOX-loaded micelles of poly(Lhistidine)-PEG-folate and PLA-PEG-folate blends [32] • Self-assembled NPs of PLGA-g-pullulan loaded with DOX [33], among others • Multifunctional micelles of PLA-PEG loaded with superparamagnetic iron oxide NPs and DOX [34] Microparticle formulations have limited clinical potential since they must be locally administered or implanted. Formulations in which DOX is chemically conjugated to the drug carrier are often problematic because modification of the drug may lead to changes in its in vivo activity and creates the risk for creation of nonbiocompatible products of drug-polymer metabolism.…”
mentioning
confidence: 99%
“…Poly(D,L-lactide-co-glycolide) (PLGA) has been previously used to prepare microspheres encapsulated with various molecules for the purpose of brain implantation (Ike et al 1991, Menei et al 1993. The biodegradation and tissue reaction of the copolymer PLGA microspheres, which were prepared by the solvent evaporation method, radiosterilized, and stereotactically implanted in the rat brain, have been studied by routine tissue staining, immunohistochemistry, and transmission electron microscopy (Menei et al 1993;Splenlehauer et al 1991).…”
mentioning
confidence: 99%
“…Son varios los trabajos reportados acerca de la liberación de diversos medicamentos como los anticancerígenos (9)(10)(11)(12)(13)(14)(15)(16)(17)(18) y antibióticos (19)(20)(21)(22) incluyendo el estudio de los biomateriales en los cuales están soportadas dichas drogas.…”
Section: Diferentes Tipos De Sistemas (Biomateria-droga)unclassified